Aptose Biosciences Inc.
NASDAQ: APTO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William G. Rice
- Employees
- 35
- Headquarters
- Toronto, Canada
- IPO year
- 1992
- Market cap
- $4.4M
- Website
- https://www.aptose.com
Loading APTO…
Loading profile data…Frequently asked questions about APTO
What does Aptose Biosciences Inc. (APTO) do?
Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO...
Where does APTO trade?
Aptose Biosciences Inc. (APTO) trades on the NASDAQ Capital Market.
What sector is APTO in?
Aptose Biosciences Inc. (APTO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aptose Biosciences Inc.?
William G. Rice is the chief executive officer of Aptose Biosciences Inc. (APTO).
Where is Aptose Biosciences Inc. headquartered?
Aptose Biosciences Inc. is headquartered in Canada.
Does APTO pay a dividend?
Aptose Biosciences Inc. (APTO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APTO go public?
Aptose Biosciences Inc. (APTO) completed its initial public offering in 1992.